Physician profile
Scott C Stallkamp
NPI 1104829043
$599.39
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $64.03 · 2021: $158 · 2022: $68.75 · 2023: $110 · 2024: $33.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $143.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $140.94 | 2019-2022 | |
| Hologic Sales and Service, LLC | $104.73 | 2021-2024 | Novasure, Acessa Provu System, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $63.75 | 2019-2020 | |
| Pfizer INC. | $55.95 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $35.28 | 2019-2020 | |
| Myovant Sciences INC. | $33.89 | 2021 | |
| Mylan Pharmaceuticals INC. | $26.12 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.50 | 2023 | |
| Aspira Women'S Health INC | $19.98 | 2022 | |
| Minerva Surgical, INC | $14.99 | 2021 | |
| Sumitomo Pharma America, INC. | $14.42 | 2023 | Myfembree |
| Coopersurgical, INC. | $14.36 | 2019 | |
| Daiichi Sankyo INC. | $13.38 | 2019 | |
| Avanos Medical | $11.72 | 2019 | |
| Allergan, INC. | $11.39 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $10.49 | 2023 | Nexplanon |
| Mayne Pharma Commercial LLC | $7.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Stallkamp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.